Skip to main content

Find Clinical Trials

Home
Conditions
Synucleinopathies

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,496 public trials 645 recruiting studies

Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone

NCT02305316

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

NCT01536366

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Bial - Portela & Cª, S.A. S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

NCT01519284

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Bial - Portela & Cª, S.A. S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Effect of BIA 9-1067 on Rasagiline Pharmacokinetics

NCT01532128

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: BIOTRIAL Rennes, France

View Trial Details

Completed

Effect of Rasagiline on BIA 9-1067 Pharmacokinetics

NCT01532141

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: BIOTRIAL Rennes, France

View Trial Details

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa

NCT02169479

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Algorithme Pharma Inc Mount Royal, Quebec, Canada

View Trial Details

Completed

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity

NCT02216188

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, 1080 Vienna Vienna, State of Vienna, Austria

View Trial Details

Completed

AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A

NCT01885494

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32 Vienna, Austria

View Trial Details

Completed

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

NCT01568099

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, 1080 Vienna Vienna, Austria

View Trial Details

Completed

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

NCT01525641

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Boehringer Ingelheim Investigational Site 28 Abiko,Chiba, Japan

Boehringer Ingelheim Investigational Site 86 Akashi,Hyogo, Japan

Boehringer Ingelheim Investigational Site 13 Akita,Akita, Japan

Boehringer Ingelheim Investigational Site 9 Aomori,Aomori, Japan

View all 118 locations

View Trial Details